Caroline Stark Beer
Equibles does not estimate personal net worth.
Get an email with a short summary when Sionna Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get SION alertsAbout Caroline Stark Beer
Sionna Therapeutics, Inc. reported in an 8-K filed September 14, 2026 that Caroline Stark Beer was terminated as Chief Business Officer, effective September 15, 2026. The proxy statement of Sionna Therapeutics, Inc. reports total compensation of $5,592,896 for Caroline Stark Beer in fiscal 2025, including a base salary of $158,945. Disclosed compensation is on record for 2 fiscal years. Sionna Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Sionna Therapeutics, Inc. includes Michael Cloonan (CEO), Elena Ridloff (CFO), H. Edward Fleming (Board Member) and 3 others.
“the employment of Caroline Stark Beer, M.B.A., the Company's Chief Business Officer, was terminated without cause, effective as of September 15, 2026.”
Affiliation history
-
Sionna Therapeutics, Inc. (SION)
Proxy statement
CurrentStart not stated–present
Last confirmed April 27, 2026
Company network
Leadership on record at Sionna Therapeutics, Inc.
- Michael Cloonan CEO
- Elena Ridloff CFO
- H. Edward Fleming Board Member
- Joanne Louise Viney Board Member
- Marcella Kuhlman Ruddy Board Member
- Peter A. Thompson Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Sionna Therapeutics, Inc. (SION) | M.B.A. Chief Business Officer | $158,945 | $5,592,896 |
| 2024 | Sionna Therapeutics, Inc. (SION) | M.B.A. Chief Business Officer | — | — |